跳至主要内容
临床试验/NCT05838001
NCT05838001招募中不适用

Efficacy and Accuracy of Combined Localization Versus Single Localization in Non-palpable Breast Cancer After Neo-adjuvant Therapy : a Prospective Randomized Control Trial.

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2023年2月16日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
110
试验地点
1
主要终点
Marginal positive rate

研究概览

简要总结

The standard method for localizing non-palpable breast cancer is currently clip localization, its positive margin rate still remains around 20-50%. This study aims to compare the accuracy and efficacy of single vs. combined breast tissue markers in localizing non-palpable breast cancer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • female patients, age≥18 year
  • A score of ≥ 2 on the Eastern Cooperative Oncology Group scale
  • Patients pathologically diagnosed with breast cancer by core-needle biopsy, received neoadjuvant treatment and the lesion becomes non-palpable before enrollment.
  • Patients are willing to undergo breast conserving surgery and have no contraindications to breast conserving surgery

排除标准

  • Inflammatory breast cancer or Paget's disease
  • Breast deformities and other conditions that impact breast conservation success rate
  • Patients with contraindications to breast-conserving surgery, as well as those with systemic diseases, mental disorders, or other subjective reasons that may affect their ability to participate in the trial. Patients with severe bleeding disorders or coagulation disorders were also excluded.
  • Pregnancy or lactation
  • Patients with hook-wire, radioactive 125I seed or other localization techniques in the breast cancer lesions before enrollment
  • Patients with stage IV diseases or unresectable lesions in either breast
  • Patients combined with other diseases that may affect survival
  • Patients with multicentric breast cancer lesions or lesions > 5 cm in diameter on imaging examinations
  • Patients who have previously undergone radical mastectomy for ipsilateral breast cancer or chest wall radiotherapy
  • Patients with history of ipsilateral breast cancer radical mastectomy or chest wall radiotherapy

结局指标

主要结局

Marginal positive rate

时间窗: up to 3 months

Proportion of patients with positive margin (intraoperative freezing and postoperative pathological margin tissue showing cancer)

次要结局

  • Re-operation rate.(up to 3 months)
  • The proportion of breast-conserving surgery.(up to 3 months)
  • IDFS(2 years, 3 years, and 5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Chang Gong

Clinical Professor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

研究点 (1)

Loading locations...

相似试验

Efficacy and Accuracy of Combined Localization... | 临床试验